Raymond James & Associates bought a new stake in shares of agilon health, inc. (NYSE:AGL – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 14,673 shares of the company’s stock, valued at approximately $184,000.
A number of other hedge funds and other institutional investors have also modified their holdings of AGL. Signaturefd LLC grew its holdings in agilon health by 73.7% during the 3rd quarter. Signaturefd LLC now owns 1,673 shares of the company’s stock worth $30,000 after acquiring an additional 710 shares in the last quarter. CWM LLC raised its stake in agilon health by 83.7% during the third quarter. CWM LLC now owns 1,585 shares of the company’s stock valued at $28,000 after buying an additional 722 shares in the last quarter. Bailard Inc. lifted its holdings in agilon health by 1.9% during the 3rd quarter. Bailard Inc. now owns 43,752 shares of the company’s stock worth $777,000 after buying an additional 803 shares during the last quarter. Arizona State Retirement System increased its holdings in shares of agilon health by 1.4% in the 3rd quarter. Arizona State Retirement System now owns 86,455 shares of the company’s stock valued at $1,535,000 after acquiring an additional 1,169 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. lifted its stake in agilon health by 17.9% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,452 shares of the company’s stock worth $274,000 after purchasing an additional 2,349 shares during the last quarter.
agilon health Price Performance
Shares of NYSE AGL opened at $4.96 on Thursday. agilon health, inc. has a twelve month low of $4.41 and a twelve month high of $26.75. The company has a current ratio of 1.51, a quick ratio of 1.51 and a debt-to-equity ratio of 0.05. The firm has a 50-day moving average of $5.49 and a two-hundred day moving average of $9.20. The company has a market capitalization of $2.04 billion, a price-to-earnings ratio of -7.62 and a beta of 0.49.
Analysts Set New Price Targets
A number of research firms have recently issued reports on AGL. TD Cowen downgraded shares of agilon health from an “outperform” rating to a “market perform” rating and reduced their price target for the stock from $12.00 to $6.50 in a research report on Monday, February 26th. Benchmark reduced their price objective on agilon health from $13.00 to $9.00 and set a “buy” rating for the company in a research report on Thursday, February 29th. Wolfe Research lowered agilon health from an “outperform” rating to a “peer perform” rating in a research report on Monday, January 8th. JPMorgan Chase & Co. downgraded shares of agilon health from an “overweight” rating to a “neutral” rating and reduced their price target for the company from $17.00 to $9.00 in a report on Friday, January 5th. Finally, Stifel Nicolaus cut their price objective on shares of agilon health from $8.00 to $7.00 and set a “hold” rating on the stock in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, twelve have issued a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, agilon health has a consensus rating of “Hold” and an average target price of $9.32.
View Our Latest Report on agilon health
agilon health Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More
- Five stocks we like better than agilon health
- Roth IRA Calculator: Calculate Your Potential Returns
- AMD is Down 35%. Now is the Time to Buy the Dip
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Amazon Stands Tall: New Highs Are in Sight
- ESG Stocks, What Investors Should Know
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGL – Free Report).
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.